These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Problems and prospects of non-invasive screening for colorectal cancer]. Maev IV; Govorun VM; Kucheriavyĭ IuA; Golubev NN; Generozov EV; Maslov VV; LiubeznovA IIu; Kostin PA Klin Med (Mosk); 2009; 87(7):10-6. PubMed ID: 19705783 [TBL] [Abstract][Full Text] [Related]
8. Genetic pathways of two types of gastric cancer. Tahara E IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305 [TBL] [Abstract][Full Text] [Related]
9. The potential of molecular screening. Ahrendt SA; Sidransky D Surg Oncol Clin N Am; 1999 Oct; 8(4):641-56, vi. PubMed ID: 10452932 [TBL] [Abstract][Full Text] [Related]
10. [DNA repair--a fundamental factor in ageing and development of cancer]. Rasmussen LJ; Stevnsner T; Bohr VA Ugeskr Laeger; 2006 Jun; 168(24):2332-5. PubMed ID: 16822413 [TBL] [Abstract][Full Text] [Related]
11. [New tumor suppressor genes in hot spots of human chromosome 3: new methods of identification]. Braga EA; Kashuba VI; Maliukova AV; Loginov VI; Senchenko VN; Bazov IV; Kiselev LL; Zabarovskiĭ ER Mol Biol (Mosk); 2003; 37(2):194-211. PubMed ID: 12723467 [TBL] [Abstract][Full Text] [Related]
12. Review of circulating tumor markers: from enzyme, carcinoembryonic protein to oncogene and suppressor gene. Wu JT Ann Clin Lab Sci; 1999; 29(2):106-11. PubMed ID: 10219697 [TBL] [Abstract][Full Text] [Related]
13. Molecular genetic tumor markers in non-small cell lung cancer. Oyama T; Osaki T; Baba T; Nagata Y; Mizukami M; So T; Nakata S; Ichiki Y; Uramoto H; Sugaya M; Yoshimatsu T; Morita M; Hanagiri T; Sugio K; Kawamoto T; Yasumoto K Anticancer Res; 2005; 25(2B):1193-6. PubMed ID: 15865065 [TBL] [Abstract][Full Text] [Related]
14. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance. Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410 [TBL] [Abstract][Full Text] [Related]
15. [Clinical application of oncogene and antioncogene as a tumor marker]. Kondo H; Nobuoka A Nihon Rinsho; 1996 Jun; 54(6):1494-8. PubMed ID: 8691599 [TBL] [Abstract][Full Text] [Related]
16. [From identification of genomic polymorphism to diagnostic and prognostic markers of human epithelial tumors]. Braga EA; Kiselev LL; Zabarovskiĭ ER Mol Biol (Mosk); 2004; 38(2):179-90. PubMed ID: 15125222 [TBL] [Abstract][Full Text] [Related]
17. Allele-specific loss of heterozygosity at the DAL-1/4.1B (EPB41L3) tumor-suppressor gene locus in the absence of mutation. Kittiniyom K; Mastronardi M; Roemer M; Wells WA; Greenberg ER; Titus-Ernstoff L; Newsham IF Genes Chromosomes Cancer; 2004 Jul; 40(3):190-203. PubMed ID: 15138999 [TBL] [Abstract][Full Text] [Related]
18. Information dynamics in carcinogenesis and tumor growth. Gatenby RA; Frieden BR Mutat Res; 2004 Dec; 568(2):259-73. PubMed ID: 15542113 [TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of prognostic significance of molecular markers of apoptosis with clinical stage and tumor differentiation in patients with colorectal cancer: a single institute experience. Ivanov K; Kolev N; Tonev A; Nikolova G; Krasnaliev I; Softova E; Tonchev A Hepatogastroenterology; 2009; 56(89):94-8. PubMed ID: 19453036 [TBL] [Abstract][Full Text] [Related]